NextFerm Technologies
Non-GMO Yeast Food ingredients
Company Overview
Snapshot
Founded in December 2013 by Boaz Noy, NextFerm Technologies operates with 11–50 employees. The company has raised $19.18M across three funding rounds from Rhodium and Daniel Recanati. A significant milestone for the company was its initial public offering on the TASE in January 2021.
Business overview
NextFerm Technologies specializes in the development, manufacturing, and marketing of novel active ingredients derived from non-GMO yeast fermentation and extraction processes. Its flagship product, Protevin, is a neutral-tasting, nutritionally rich vegan protein produced sustainably and cost-effectively. The company primarily serves the food and beverage industry, with applications in dairy and powder pre-mixes, and operates within the Agriculture & Food Technologies sector, focusing on novel food and sustainable proteins.
Strategic signal
In March 2024, NextFerm Technologies announced a significant international collaboration, completing the first phase of its commercial manufacturing setup in India. This strategic expansion into a key market signals the company's commitment to scaling production and distribution of its ProteVin vegan protein, indicating a strong push for global market penetration and increased revenue potential for investors.
Log in to access full profile ›Company Intelligence Q&A
- What is NextFerm Technologies' primary product?
- NextFerm Technologies' leading product is Protevin, a non-GMO yeast-derived vegan protein with a neutral taste and nutritional profile, produced sustainably through fermentation.
- When did NextFerm Technologies become publicly traded?
- NextFerm Technologies completed its initial public offering on the TASE in January 2021.
- What was a key strategic development for ProteVin in September 2022?
- In September 2022, NextFerm Technologies announced a strategic manufacturing agreement for the production of ProteVin with a subcontractor in Europe.
- What was a significant commercial milestone for ProteVin in the US?
- In June 2022, NextFerm Technologies announced its first commercial delivery of ProteVin in the U.S.
- What recent manufacturing expansion did NextFerm Technologies undertake?
- In March 2024, NextFerm Technologies completed the first phase of its commercial manufacturing setup in India, as part of an international collaboration.